At Medolac Laboratories, we are dedicated to the fundamental principle that all babies everywhere should have access to breast milk, either from their own mothers or milk from qualified donors adapted for clinical use. An impressive array of studies support the exclusive use of human milk for preterm infants yet the current supply is only enough to provide for a small fraction of the most fragile babies. The scarcity of donor milk continues to grow with increasing demand and the inability of existing milk banks to effectively scale. Women are expected to donate their milk while others profit in a system that places a high price on human milk and little or no value on milk donors. Learn more about our vision.
Medolac Laboratories’ dedication to ongoing research in the area of human breast milk sets us apart. Milk banking should be guided by evidence-based practices founded upon disciplined research and rigorous scientific methods. Unfortunately, many current milk banking practices lack these science-based insights. We are committed to finding ways to improve supply and clinical care including novel milk banking models. Learn more about Medolac Research and Development.
Using processing methods developed over the past three years, Medolac is providing a range of new human milk fortifiers and other human milk-based products for use in clinical and post discharge settings. Medolac products are formulated to meet nutritional targets for preterm babies, and packaged in a way to maximize the safe storage, preparation and clinical use of our products. At Medolac we are committed to only sourcing our products from milk banks that empower donors and promote their interests. We are also proud to be the first company primarily focused on the use of human milk in clinical settings to develop a publically available "Commitment to Responsible Conduct."
Medolac Laboratories Announces Clinton Global Initiative (CGI) Commitment to Action at 2014 CGI Annual Meeting
Medolac Laboratories (Medolac) believes that breast milk is the optimal nutrition for full-term newborns and is dedicated to ensuring that premature infants and young children with special medical needs should also have access to safe, high quality, breast-milk based nutrition adapted for clinical settings. Learn more about our Commitment to Corporate Responsibility.
The safety of our products is a foundational value at Medolac. We adhere to Current Good Manufacturing Practices (CGMPs) for food as outlined by the US Food and Drug Administration and other international, federal and local requirements. Our methods, equipment, facilities, and controls for producing processed human milk are structured to meet or exceed those requirements. In States or countries where breast milk products are regulated as human tissue, we will always meet or exceed those requirements as well. Learn more about Medolac Product Safety here.